Impact of radiation therapy on survival in patients with triple-negative breast cancer

Oncology Letters

Volumn 7, Issue 2, 2014, Pages 548-552

  Steward, Lauren T ^a   Gao, Feng ^a   Taylor, Marie A ^a   Margenthaler, Julie A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Radiation therapy; Survival; Triple negative breast cancer

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; OVERALL SURVIVAL; RADIATION DOSE; SURVIVAL RATE; TRIPLE NEGATIVE BREAST CANCER;

EID: 84890408318     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1700     Document Type: Article

References (14)

1. Zaky SS, Lund M, May KA, et al: The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy. Ann Surg Oncol 18: 2858-2865, 2011.
2. Fornier M and Fumoleau P: The paradox of triple negative breast cancer: novel approaches to treatment. Breast J 18: 41-51, 2012.
3. Carey LA, Perou CM, Livasy CA, et al: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295: 2492-2502, 2006.
4. Houssami N, Macaskill P, von Minckwitz G, Marinovich ML and Mamounas E: Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy. Eur J Cancer 48: 3342-3354, 2012.
5. Asaga S, Kinoshita T, Hojo T, Suzuki J, Jimbo K and TsudaH: Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy. Clin Breast Cancer 13: 40-46, 2013.
6. Lowery AJ, Kell MR, Glynn RW, Kerin MJ and Sweeney KJ: Locoregional recurrence after breast cancer surgery: a systematicreview by receptor phenotype. Breast Cancer Res Treat 133: 831-841, 2012.
7. Billar JA, Dueck AC, Stucky CC, et al: Triple-negative breast cancers: unique clinical presentations and outcomes. Ann Surg Oncol 17 (Suppl 3): 384-390, 2010.
8. Dent R, Trudeau M, Pritchard KI, et al: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13: 4429-4434, 2007.
9. Abdulkarim B, Cuartero J, Hanson J, Deschênes J, Lesniak D and Sabri S: Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy. J Clin Oncol 29: 2852-2858, 2011.
10. Wang J, Shi M, Ling R, et al: Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial. Radiother Oncol 100: 200-204, 2011.
11. Haffty BG, Yang Q, Reiss M, et al: Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24: 5652-5657, 2006.
12. Panoff JE, Hurley J, Takita C, et al: Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation. Breast Cancer Res Treat 128: 899-906, 2011.
13. Dragun AE, Pan J, Rai SN, Kruse B and Jain DL: Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study. Am J Clin Oncol34: 231-237, 2011.
14. Kyndi M, Sørensen FB, Knudsen H, et al; Danish Breast Cancer Cooperative Group: Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26: 1419-1426, 2008.